ISS-IP1: A phase III, randomised, comparative multicenter trial of ritonavir versus indinavir in 1251 nucleoside-experienced patients with less than 50 CD4/mm(3)
AIDS（1998）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined